Fri Dec 12 18:14:47 UTC 2025: Okay, here’s a news article summary of the provided text:

Summary:

Vignan’s Foundation for Science, Technology and Research in Andhra Pradesh has partnered with Ipseity Diagnostics and Research, a US-based molecular diagnostics company, to advance biomedical innovation in the region. The collaboration will focus on bringing cutting-edge molecular technologies like transcriptomics, low-cost PCR, and Next Generation Sequencing (NGS) to Andhra Pradesh. The goal is to develop affordable and accessible diagnostic solutions for critical illnesses like sepsis and drug-resistant infections, ultimately benefiting patients in the Indian healthcare system.

News Article:

Andhra Pradesh Aims to Become Biomedical Hub with US Partnership

GUNTUR, December 12, 2025 – Vignan’s Foundation for Science, Technology and Research has joined forces with Ipseity Diagnostics and Research, a leading molecular diagnostics company based in the United States, to drive biomedical advancements in Andhra Pradesh. The Memorandum of Understanding (MoU) was officially signed on Friday at the Vignan University campus, witnessed by Chairman Lavu Rathaiah and representatives from both institutions.

This collaboration is set to introduce advanced technologies such as transcriptomics, affordable PCR methods, and Next Generation Sequencing (NGS) to the state. The partnership aims to bridge the gap between laboratory research and patient care, bringing innovative diagnostic solutions to those suffering from critical conditions like sepsis and drug-resistant infections.

“This partnership positions Andhra Pradesh as an emerging hub for high-end biomedical research and could benefit millions of patients through faster, more accurate, and cost-effective diagnostic tools,” said Dr. Kalyan Chakravarthy, CMO of Ipseity Diagnostics.

The initiative is also geared towards developing indigenous and cost-effective technologies specifically tailored to the Indian healthcare landscape, making advanced diagnostics more accessible to the population. With this significant investment in molecular science, Andhra Pradesh is poised to become a key player in the field of biomedical research and development.

Read More